1. Home
  2. TEAM vs INSM Comparison

TEAM vs INSM Comparison

Compare TEAM & INSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Atlassian Corporation

TEAM

Atlassian Corporation

N/A

Current Price

$78.04

Market Cap

43.3B

Sector

Technology

ML Signal

N/A

Logo Insmed Incorporated

INSM

Insmed Incorporated

N/A

Current Price

$144.14

Market Cap

35.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TEAM
INSM
Founded
2002
1988
Country
Australia
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
43.3B
35.2B
IPO Year
2015
2000

Fundamental Metrics

Financial Performance
Metric
TEAM
INSM
Price
$78.04
$144.14
Analyst Decision
Buy
Strong Buy
Analyst Count
24
23
Target Price
$206.42
$188.73
AVG Volume (30 Days)
7.1M
2.2M
Earning Date
05-08-2026
05-21-2026
Dividend Yield
N/A
N/A
EPS Growth
15.52
N/A
EPS
N/A
N/A
Revenue
$5,215,304,000.00
N/A
Revenue This Year
$24.63
$168.46
Revenue Next Year
$17.66
$65.97
P/E Ratio
N/A
N/A
Revenue Growth
19.66
N/A
52 Week Low
$67.85
$60.40
52 Week High
$242.00
$212.75

Technical Indicators

Market Signals
Indicator
TEAM
INSM
Relative Strength Index (RSI) 36.84 40.80
Support Level $67.85 $139.81
Resistance Level $177.94 $149.08
Average True Range (ATR) 4.72 6.51
MACD 2.70 -0.40
Stochastic Oscillator 59.53 17.14

Price Performance

Historical Comparison
TEAM
INSM

About TEAM Atlassian Corporation

Atlassian produces software that helps teams work together more efficiently and effectively. The company provides project planning and management software, collaboration tools, and IT help desk solutions. The company operates in four segments: subscriptions (term licenses and cloud agreements), maintenance (annual maintenance contracts that provide support and periodic updates and are generally attached to perpetual license sales), perpetual license (upfront sale for indefinite usage of the software), and other (training, strategic consulting, and revenue from the Atlassian Marketplace app store). Atlassian was founded in 2002 and is headquartered in Sydney.

About INSM Insmed Incorporated

Insmed Inc is a biopharmaceutical company. Its commercial portfolio and clinical pipeline are organized around three therapeutic areas: Respiratory, Immunology and Inflammation, and Neuro and Other Rare. The company's two commercial products, Arikayce and Brinsupri, are both part of the Respiratory therapeutic area. The firm's clinical-stage programs are TPIP, INS1148, brensocatib, and INS1201, focusing on different therapeutic areas. Additionally, Insmed's pre-clinical research programs encompass various technologies and modalities, including gene therapy, AI-driven protein engineering, protein manufacturing, RNA end-joining, and synthetic rescue. Geographically, the company generates maximum revenue from the United States from the sale of its commercial products.

Share on Social Networks: